{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:24:09Z","timestamp":1791869049009,"version":"4.3.4"},"reference-count":89,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2023,7,1]]},"abstract":"<jats:sec id=\"ab-csc230001-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Thymic carcinoma is rare, and its oncologic management is controversial due to a paucity of prospective data. For this reason, multidisciplinary consensus guidelines are crucial to guide oncologic management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-csc230001-2\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop expert multidisciplinary consensus guidelines on the management of common presentations of thymic carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-csc230001-3\">\n                    <jats:title>Evidence Review<\/jats:title>\n                    <jats:p>Case variants spanning the spectrum of stage I to IV thymic carcinoma were developed by the 15-member multidisciplinary American Radium Society (ARS) Thoracic Appropriate Use Criteria (AUC) expert panel to address management controversies. A comprehensive review of the English-language medical literature from 1980 to 2021 was performed to inform consensus guidelines. Variants and procedures were evaluated by the panel using modified Delphi methodology. Agreement\/consensus was defined as less than or equal to 3 rating points from median. Consensus recommendations were then approved by the ARS Executive Committee and subject to public comment per established ARS procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-csc230001-4\">\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>The ARS Thoracic AUC panel identified 89 relevant references and obtained consensus for all procedures evaluated for thymic carcinoma. Minimally invasive thymectomy was rated as usually inappropriate (regardless of stage) due to the infiltrative nature of thymic carcinomas. There was consensus that conventionally fractionated radiation (1.8-2 Gy daily) to a dose of 45 to 60 Gy adjuvantly and 60 to 66 Gy in the definitive setting is appropriate and that elective nodal irradiation is inappropriate. For radiation technique, the panel recommended use of intensity-modulated radiation therapy or proton therapy (rather than 3-dimensional conformal radiotherapy) to reduce radiation exposure to the heart and lungs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-csc230001-5\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The ARS Thoracic AUC panel has developed multidisciplinary consensus guidelines for various presentations of thymic carcinoma, perhaps the most well referenced on the topic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaoncol.2023.1175","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T13:30:54Z","timestamp":1684157454000},"page":"971","source":"Crossref","is-referenced-by-count":10,"title":["American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma"],"prefix":"10.1001","volume":"9","author":[{"given":"Stephen G.","family":"Chun","sequence":"first","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rimner","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Amini","sequence":"additional","affiliation":[{"name":"City of Hope National Medical Center, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe Y.","family":"Chang","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Donington","sequence":"additional","affiliation":[{"name":"University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Edelman","sequence":"additional","affiliation":[{"name":"Fox Chase Comprehensive Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Geng","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Gubens","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin A.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneeth","family":"Iyengar","sequence":"additional","affiliation":[{"name":"The University of Texas at Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Movsas","sequence":"additional","affiliation":[{"name":"Henry Ford Cancer Institute, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Ning","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry S.","family":"Park","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Wolf","sequence":"additional","affiliation":[{"name":"Mount Sinai Health System, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[{"name":"New York Proton Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"csc230001r1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227197","article-title":"Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States.","volume":"14","author":"Hsu","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"csc230001r2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jtho.2022.01.021","article-title":"Thymic carcinomas\u2014a concise multidisciplinary update on recent developments from the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group.","volume":"17","author":"Roden","year":"2022","journal-title":"J Thorac Oncol"},{"issue":"4","key":"csc230001r3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/0003-4975(95)00669-C","article-title":"Thymoma: a multivariate analysis of factors predicting survival.","volume":"60","author":"Blumberg","year":"1995","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"csc230001r4","first-page":"764","article-title":"Prognosis of thymic carcinoma: analysis of 16 cases.","volume":"91","author":"Chang","year":"1992","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"csc230001r5","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S0003-4975(01)03607-4","article-title":"Primary thymic carcinoma.","volume":"73","author":"Liu","year":"2002","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"csc230001r6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S1010-7940(01)00666-2","article-title":"The multimodality treatment of thymic carcinoma.","volume":"19","author":"Lucchi","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"csc230001r7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ijrobp.2009.02.016","article-title":"Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease.","volume":"76","author":"Forquer","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"csc230001r8","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/cncr.v121.7","article-title":"Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study.","volume":"121","author":"Omasa","year":"2015","journal-title":"Cancer"},{"issue":"5","key":"csc230001r9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cllc.2016.05.019","article-title":"Adjuvant proton beam therapy in the management of thymoma: a dosimetric comparison and acute toxicities.","volume":"17","author":"Parikh","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"7","key":"csc230001r10","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1080\/0284186X.2019.1575981","article-title":"Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the Proton Collaborative Group and the University of Florida prospective registries.","volume":"58","author":"Mercado","year":"2019","journal-title":"Acta Oncol"},{"issue":"3","key":"csc230001r11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.radonc.2016.02.003","article-title":"Prospective study of proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma: early response and toxicity assessment.","volume":"118","author":"Vogel","year":"2016","journal-title":"Radiother Oncol"},{"issue":"1","key":"csc230001r12","first-page":"1","article-title":"Minimally invasive versus open thymectomy: a systematic review of surgical techniques, patient demographics, and perioperative outcomes.","volume":"5","author":"Hess","year":"2016","journal-title":"Ann Cardiothorac Surg"},{"issue":"3","key":"csc230001r13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1470-2045(18)30062-7","article-title":"Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study.","volume":"19","author":"Giaccone","year":"2018","journal-title":"Lancet Oncol"},{"issue":"24","key":"csc230001r14","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1200\/JCO.2017.77.3184","article-title":"Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial.","volume":"37","author":"Cho","year":"2019","journal-title":"J Clin Oncol"},{"issue":"4","key":"csc230001r15","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jtho.2016.11.2219","article-title":"Thymic carcinoma management patterns among International Thymic Malignancy Interest Group (ITMIG) physicians with consensus from the Thymic Carcinoma Working Group.","volume":"12","author":"Shepherd","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"1","key":"csc230001r16","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/j.cllc.2018.09.007","article-title":"Elective nodal irradiation as adjuvant radiotherapy for advanced thymomas and thymic carcinomas.","volume":"20","author":"Kim","year":"2019","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"csc230001r17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0360-3016(01)02656-6","article-title":"Postoperative radiotherapy in thymic carcinoma: treatment results and prognostic factors.","volume":"52","author":"Hsu","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"csc230001r18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.21037\/jtd","article-title":"The role of postoperative radiotherapy for stage I\/II\/III thymic tumor-results of the ChART retrospective database.","volume":"8","author":"Liu","year":"2016","journal-title":"J Thorac Dis"},{"key":"csc230001r19","first-page":"2503","article-title":"Treatment and survival analyses of completely resected thymic carcinoma patients.","volume":"8","author":"Mao","year":"2015","journal-title":"Onco Targets Ther"},{"issue":"1","key":"csc230001r20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/JTO.0b013e318276241c","article-title":"Thymoma: a population-based study of the management and outcomes for the province of British Columbia.","volume":"8","author":"Mariano","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"3","key":"csc230001r21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4143\/crt.2012.44.3.166","article-title":"Is there a role of postoperative radiation therapy in completely resected stage I\/II thymic epithelial tumor?","volume":"44","author":"Oh","year":"2012","journal-title":"Cancer Res Treat"},{"issue":"4","key":"csc230001r22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/JTO.0000000000000128","article-title":"Thymic carcinoma: a cohort study of patients from the European Society of Thoracic Surgeons database.","volume":"9","author":"Ruffini","year":"2014","journal-title":"J Thorac Oncol"},{"key":"csc230001r23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/00015458.2015.11681067","article-title":"Single-centre 20-year experience with surgical treatment of thymic tumours.","volume":"115","author":"Viskens","year":"2015","journal-title":"Acta Chir Belg"},{"issue":"5","key":"csc230001r24","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.athoracsur.2012.01.014","article-title":"Thymic carcinoma: outcomes after surgical resection.","volume":"93","author":"Okereke","year":"2012","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"csc230001r25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jso.23256","article-title":"Long-term survival in thymic epithelial tumors: a single-center experience from China.","volume":"107","author":"Shen","year":"2013","journal-title":"J Surg Oncol"},{"issue":"3","key":"csc230001r26","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.athoracsur.2004.03.097","article-title":"Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification.","volume":"78","author":"Park","year":"2004","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"csc230001r27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","article-title":"Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"csc230001r28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijrobp.2019.12.045","article-title":"Intensity modulated radiation therapy plus etoposide\/cisplatin for patients with limited advanced unresectable thymic epithelial tumors: a prospective phase 2 study.","volume":"107","author":"Fan","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"csc230001r29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0360-3016(99)00514-3","article-title":"Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study.","volume":"46","author":"Myojin","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"csc230001r30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1148\/radiology.204.3.9280272","article-title":"Invasive thymoma: treatment with postoperative radiation therapy.","volume":"204","author":"Latz","year":"1997","journal-title":"Radiology"},{"issue":"1","key":"csc230001r31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13019-020-01316-7","article-title":"Extended thymectomy with blood vessel resection and reconstruction improves therapeutic outcome for clinical stage III thymic carcinoma patients: a real-world research.","volume":"15","author":"Liu","year":"2020","journal-title":"J Cardiothorac Surg"},{"issue":"9","key":"csc230001r32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/jjco\/hyd108","article-title":"Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma.","volume":"30","author":"Nakamura","year":"2000","journal-title":"Jpn J Clin Oncol"},{"issue":"7","key":"csc230001r33","first-page":"515","article-title":"Concurrent chemoradiotherapy for unresectable thymic carcinoma.","volume":"27","author":"Chen","year":"2004","journal-title":"Chang Gung Med J"},{"issue":"3","key":"csc230001r34","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/BF02468753","article-title":"Thymoma: clinicopathologic features, therapy, and prognosis.","volume":"10","author":"Hara","year":"1980","journal-title":"Jpn J Surg"},{"issue":"3","key":"csc230001r35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/02841868109130192","article-title":"Radiation therapy in the management of malignant thymic tumors.","volume":"20","author":"Arriagada","year":"1981","journal-title":"Acta Radiol Oncol"},{"key":"csc230001r36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejca.2019.03.012","article-title":"Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study.","volume":"113","author":"Katsuya","year":"2019","journal-title":"Eur J Cancer"},{"issue":"4","key":"csc230001r37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/00000441-200510000-00004","article-title":"Stage IV thymic carcinoma: a study of 20 patients.","volume":"330","author":"Lin","year":"2005","journal-title":"Am J Med Sci"},{"issue":"2","key":"csc230001r38","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jtcvs.2019.08.037","article-title":"Long-term, disease-specific outcomes of thymic malignancies presenting with de novo pleural metastasis.","volume":"159","author":"Choe","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"csc230001r39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0167-8140(92)90227-L","article-title":"Aggressive treatment of intrathoracic recurrences of thymoma.","volume":"24","author":"Urgesi","year":"1992","journal-title":"Radiother Oncol"},{"issue":"5","key":"csc230001r40","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.ejcts.2010.12.064","article-title":"Long-term outcome of pleuropneumonectomy for Masaoka stage IVa thymoma.","volume":"39","author":"Fabre","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"csc230001r41","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.athoracsur.2009.05.019","article-title":"Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy.","volume":"88","author":"Ishikawa","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"csc230001r42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/(ISSN)1096-9098","article-title":"Recurrence of thymoma: clinicopathological features, re-operation, and outcome.","volume":"78","author":"Haniuda","year":"2001","journal-title":"J Surg Oncol"},{"issue":"4","key":"csc230001r43","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/jrr\/rrab046","article-title":"Local radiotherapy for pleural dissemination of thymic tumors after initial treatment.","volume":"62","author":"Okazaki","year":"2021","journal-title":"J Radiat Res"},{"issue":"1","key":"csc230001r44","doi-asserted-by":"publisher","first-page":"13549","DOI":"10.1038\/s41598-017-12909-z","article-title":"Prospective study of stereotactic body radiation therapy for thymoma and thymic carcinoma: therapeutic effect and toxicity assessment.","volume":"7","author":"Hao","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"csc230001r45","first-page":"399","article-title":"The role of low-dose hemithoracic radiotherapy for thoracic dissemination of thymoma.","volume":"15","author":"Yoshida","year":"1997","journal-title":"Radiat Med"},{"issue":"8","key":"csc230001r46","article-title":"Chemotherapy for thymic carcinoma and advanced thymoma in adults.","volume":"2013","author":"Wei","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"csc230001r47","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1111\/tca.v10.11","article-title":"Optimal first-line treatment for advanced thymic carcinoma.","volume":"10","author":"Yang","year":"2019","journal-title":"Thorac Cancer"},{"issue":"3","key":"csc230001r48","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jtho.2020.11.003","article-title":"Durable response in patients with thymic carcinoma treated with pembrolizumab after prolonged follow-up.","volume":"16","author":"Giaccone","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"6","key":"csc230001r49","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/ejcts\/ezy239","article-title":"Video-assisted thoracoscopic surgery versus open surgery for stage I thymic epithelial tumours: a propensity score-matched study.","volume":"54","author":"Gu","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"csc230001r50","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0003-4975(98)00350-6","article-title":"Surgery for invasive primary mediastinal tumors.","volume":"66","author":"Bacha","year":"1998","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"csc230001r51","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/01.coc.0000046301.83671.09","article-title":"Multimodality therapy for thymic carcinoma (TCA): results of a 30-year single-institution experience.","volume":"27","author":"Hernandez-Ilizaliturri","year":"2004","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"csc230001r52","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000097944","article-title":"Persistent and aggressive treatment for thymic carcinoma: results of a single-institute experience with 25 patients.","volume":"70","author":"Maruyama","year":"2006","journal-title":"Oncology"},{"issue":"6","key":"csc230001r53","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/S0003-4975(03)01020-8","article-title":"Long-term outcome after multimodality treatment for stage III thymic tumors.","volume":"76","author":"Venuta","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"csc230001r54","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11748-008-0227-x","article-title":"Thymic carcinoma with dissemination: a retrospective analysis of ten patients.","volume":"56","author":"Yano","year":"2008","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"2","key":"csc230001r55","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/COC.0000000000000024","article-title":"Treatment modalities and outcomes in patients with advanced invasive thymoma or thymic carcinoma: a retrospective multicenter study.","volume":"39","author":"Modh","year":"2016","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"csc230001r56","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0022-5223(94)70112-1","article-title":"Thymic carcinoma: ten years\u2019 experience in twenty patients.","volume":"107","author":"Hsu","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"csc230001r57","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jtho.2017.01.002","article-title":"The impact of postoperative radiotherapy for thymoma and thymic carcinoma.","volume":"12","author":"Jackson","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"4","key":"csc230001r58","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.athoracsur.2020.10.032","article-title":"Modified subxiphoid thoracoscopic thymectomy for locally invasive thymoma.","volume":"112","author":"Jiang","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"csc230001r59","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ijsu.2018.04.018","article-title":"The role of postoperative radiation therapy for completely resected stage III thymoma and effect of higher heart radiation dose on risk of cardiovascular disease: a retrospective cohort study.","volume":"53","author":"Liao","year":"2018","journal-title":"Int J Surg"},{"issue":"4","key":"csc230001r60","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.athoracsur.2020.06.078","article-title":"Prognostic factor of completely resected and pathologic T3 N0 M0 thymic epithelial tumor.","volume":"111","author":"Tang","year":"2021","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"csc230001r61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146609","article-title":"Adjuvant therapy for thymic carcinoma\u2014a decade of experience in a Taiwan national teaching hospital.","volume":"11","author":"Tseng","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"csc230001r62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/sj.bjc.6603833","article-title":"A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management.","volume":"97","author":"Lee","year":"2007","journal-title":"Br J Cancer"},{"issue":"12","key":"csc230001r63","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/jjco\/hyh141","article-title":"The role of radiotherapy for thymic carcinoma.","volume":"34","author":"Nonaka","year":"2004","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"csc230001r64","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.ejcts.2009.11.001","article-title":"Predictors of survival in patients with locally advanced thymoma and thymic carcinoma (Masaoka stages III and IVa).","volume":"37","author":"Cardillo","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"csc230001r65","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00066-014-0740-z","article-title":"Postoperative radiotherapy of patients with thymic epithelial tumors (TET): a retrospective analysis of outcome and toxicity.","volume":"191","author":"H\u00e4fner","year":"2015","journal-title":"Strahlenther Onkol"},{"issue":"28","key":"csc230001r66","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000324","article-title":"Long-term follow-up and prognostic factors for advanced thymic carcinoma.","volume":"93","author":"Wu","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"csc230001r67","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/JTO.0b013e3181653c71","article-title":"Thymic carcinoma: 30 cases at a single institution.","volume":"3","author":"Yano","year":"2008","journal-title":"J Thorac Oncol"},{"issue":"5","key":"csc230001r68","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.athoracsur.2017.06.025","article-title":"A single-center analysis of the treatment and prognosis of patients with thymic carcinoma.","volume":"104","author":"Zhai","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"csc230001r69","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan.","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"csc230001r70","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.athoracsur.2019.11.009","article-title":"The role of adjuvant therapy in advanced thymic carcinoma: a National Cancer Database analysis.","volume":"109","author":"Kim","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"csc230001r71","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.lungcan.2017.03.020","article-title":"Improved survival with postoperative radiotherapy in thymic carcinoma: a propensity-matched analysis of Surveillance, Epidemiology, and End Results (SEER) database.","volume":"108","author":"Lim","year":"2017","journal-title":"Lung Cancer"},{"issue":"12","key":"csc230001r72","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.jtho.2016.07.032","article-title":"Postoperative radiotherapy in locally invasive malignancies of the thymus: patterns of care and survival.","volume":"11","author":"Boothe","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"1","key":"csc230001r73","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jtcvs.2014.09.124","article-title":"Thymic carcinoma outcomes and prognosis: results of an international analysis.","volume":"149","author":"Ahmad","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"csc230001r74","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ejcts\/ezv239","article-title":"Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study.","volume":"49","author":"Hishida","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"csc230001r75","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.2147\/OTT","article-title":"Postoperative radiotherapy and tumor recurrence after complete resection of stage II\/III thymic tumor: a meta-analysis of cohort studies.","volume":"9","author":"Ma","year":"2016","journal-title":"Onco Targets Ther"},{"issue":"4","key":"csc230001r76","doi-asserted-by":"publisher","first-page":"696","DOI":"10.21037\/jtd","article-title":"The application of postoperative chemotherapy in thymic tumors and its prognostic effect.","volume":"8","author":"Ma","year":"2016","journal-title":"J Thorac Dis"},{"issue":"5","key":"csc230001r77","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.athoracsur.2008.11.022","article-title":"Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis.","volume":"87","author":"Korst","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"csc230001r78","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jtho.2020.12.023","article-title":"Postoperative radiotherapy for completely resected Masaoka\/Masaoka-Koga stage II\/III thymoma improves overall survival: an updated meta-analysis of 4746 patients.","volume":"16","author":"Tateishi","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"12","key":"csc230001r79","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases.","volume":"94","author":"Ogawa","year":"2002","journal-title":"Cancer"},{"issue":"2","key":"csc230001r80","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.lungcan.2013.11.015","article-title":"Outcome of surgically resected thymic carcinoma: a multicenter experience.","volume":"83","author":"Filosso","year":"2014","journal-title":"Lung Cancer"},{"issue":"5","key":"csc230001r81","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/0300891620967980","article-title":"Role of modern neoadjuvant chemoradiotherapy in locally advanced thymic epithelial neoplasms.","volume":"107","author":"Zhai","year":"2021","journal-title":"Tumori"},{"issue":"2","key":"csc230001r82","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jtho.2016.09.118","article-title":"Radiologic response to neoadjuvant treatment predicts histologic response in thymic epithelial tumors.","volume":"12","author":"Johnson","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"11","key":"csc230001r83","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.jtho.2018.08.005","article-title":"Systemic therapy in advanced thymic epithelial tumors: insights from the RYTHMIC prospective cohort.","volume":"13","author":"Merveilleux du Vignaux","year":"2018","journal-title":"J Thorac Oncol"},{"key":"csc230001r84","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.lungcan.2016.01.008","article-title":"Induction therapy followed by surgical resection in stage-III thimic epithelial tumors: long-term results from a multicentre analysis of 108 cases.","volume":"93","author":"Cardillo","year":"2016","journal-title":"Lung Cancer"},{"issue":"3","key":"csc230001r85","first-page":"1011","article-title":"A single-institution analysis of thymic carcinoma treated with multi-modality therapy.","volume":"1","author":"Mohiuddin","year":"2017","journal-title":"Ann Radiat Ther Oncol"},{"issue":"2","key":"csc230001r86","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ejcts.2004.03.043","article-title":"Thymic carcinoma: clinical institutional experience with 15 patients.","volume":"26","author":"Takeda","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"csc230001r87","doi-asserted-by":"publisher","first-page":"705","DOI":"10.21037\/jtd","article-title":"Outcome of nonsurgical treatment for locally advanced thymic tumors.","volume":"8","author":"Wang","year":"2016","journal-title":"J Thorac Dis"},{"issue":"2","key":"csc230001r88","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.canrad.2020.06.026","article-title":"The safety and efficacy of Cyberknife\u00ae for thymic malignancy.","volume":"25","author":"Xu","year":"2021","journal-title":"Cancer Radiother"},{"issue":"10","key":"csc230001r89","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.21037\/jtd","article-title":"Chemoradiotherapy for unresectable cases of thymic epithelial tumors: a retrospective study.","volume":"9","author":"Kashima","year":"2017","journal-title":"J Thorac Dis"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2805042\/jamaoncology_chun_2023_sc_230001_1689819958.49349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T12:04:58Z","timestamp":1689854698000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2805042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":89,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2023.1175","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,1]]}}}